Viatris Inc - Company Profile

All the data and insights you need on Viatris Inc in one report.

$295

Buy Report View Sample

Save hours of research time and resources with
our up-to-date Viatris Inc Strategy Report
Understand Viatris Inc position in the market,
performance and strategic initiatives.
Gain competitive edge and increase your
chances of success

Viatris Inc: Patents

View up-to-date information on Viatris Inc patents, including inventor and filing insights.

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
EP3965769B1	Grant	VERWENDUNG VON 2-PHENYL-6-(1H-IMIDAZOL-1-YL)CHINAZOLIN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN, INSBESONDERE MORBUS ALZHEIMER	A61K31/517; A61K45/06; A61P25/00; A61P25/14; A61P25/16; A61P25/28; A61P31/12	September 07, 2022
WO2022157747A3	Application	PHARMACEUTICAL GLP PEPTIDE COMPOSITIONS AND METHODS OF PREPARATION THEREOF	A61K38/26; A61K47/42; A61K9/0019; A61K9/08; A61P3/10	September 01, 2022
US20220273534A1	Application	LIQUID ORAL CARE COMPOSITION	A61K8/20; A61K8/27; A61K8/41; A61K8/43; A61Q11/00	September 01, 2022
US20220257598A1	Application	Use of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline for Treating Neurodegenerative Diseases, Preferably Alzheimer's Disease	A61K31/517; A61K45/06; A61P25/28	August 18, 2022
WO2022168115A1	Application	A PROCESS FOR THE PREPARATION OF LAROTRECTINIB OR ITS SALTS	C07D487/04	August 11, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer